{
  "ticker": "LLY",
  "target_date": "2025-07-31",
  "actual_date": "2025-07-31",
  "collected_at": "2025-12-08T12:05:09.998033",
  "price": {
    "open": 744.57,
    "high": 763.65,
    "low": 732.75,
    "close": 737.3651733398438,
    "volume": 5810300,
    "change_1d_pct": -2.63,
    "change_7d_pct": -4.68,
    "change_30d_pct": -6.47
  },
  "technicals": {
    "rsi_14": 38.14,
    "sma_20": 778.28,
    "sma_50": 770.01,
    "macd": -2.733,
    "macd_signal": 1.341,
    "macd_histogram": -4.074,
    "bb_upper": 815.94,
    "bb_lower": 740.62,
    "price_vs_sma20_pct": -5.26,
    "price_vs_sma50_pct": -4.24,
    "volume_ratio": 1.73
  },
  "fundamentals": {
    "market_cap": 892077539328,
    "pe_ratio": 48.75625,
    "forward_pe": 43.915047,
    "price_to_book": 37.46668,
    "price_to_sales": 15.013136,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.53
  },
  "macro": {
    "spy": {
      "price": 630.33,
      "change_1d_pct": -0.38,
      "change_7d_pct": -0.34
    },
    "vix": {
      "level": 16.72,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.36
    },
    "dollar_index": {
      "level": 100.03
    },
    "gold": {
      "price": 3293.2
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Franklin Biotechnology Discovery Fund Q2 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1753997700,
      "summary": "Franklin Templeton\u00e2\u0080\u0099s Biotechnology Discovery Fund sees long-term potential despite Q2 losses. Explore how innovation and AI are shaping its outlook.",
      "url": "https://finnhub.io/api/news?id=d61632bb7ac932a66ab21f6c57260f4bb79e88518f44428ce4f279a1392e761e"
    },
    {
      "headline": "Stock Market Today: Indexes Trim Gains, Copper Plunges Again; Meta, Carvana Build Alternate Entries (Live Coverage)",
      "source": "Yahoo",
      "datetime": 1753979467,
      "summary": "The Dow Jones index rose Thursday as it appeared a China trade deal was near. Nvidia partner Arm plunged on earnings.",
      "url": "https://finnhub.io/api/news?id=15273a4349d44a1fd9f5575c956fee9564fa0e77519464a9cf25d343b8a2a1df"
    },
    {
      "headline": "What Trump's Big Pharma CEO letters mean for drug pricing power",
      "source": "Yahoo",
      "datetime": 1753992991,
      "summary": "President Trump is turning up the heat on Big Pharma, sending letters to 17 major drugmakers demanding lower prices across their entire portfolios. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to explain how the administration is pushing for most-favored-nation pricing and ",
      "url": "https://finnhub.io/api/news?id=4833e7f299553f7689706923f0de2bea0e4ca660804c1eee2c139edccb399c18"
    },
    {
      "headline": "Eli Lilly and Company (LLY): We Sold Some Lilly, Says Jim Cramer",
      "source": "Yahoo",
      "datetime": 1753991690,
      "summary": "We recently published 12 Stocks Jim Cramer Recently Discussed As He Commented On A \u201cSea Of Green\u201d. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Weight loss drug giant Eli Lilly and Company (NYSE:LLY)\u2019s shares have struggled in 2025 as they have lost 2.3% year-",
      "url": "https://finnhub.io/api/news?id=78e32c638620e5bcfba032443c837bbeb4074b18e64369dd2d45f414b3472b2b"
    },
    {
      "headline": "Trump sends letters to pharma CEOs demanding they reduce drug prices in 60 days",
      "source": "Yahoo",
      "datetime": 1753990810,
      "summary": "President Trump sent letters to 17 CEOs of drug companies to force them to reduce prices within 60 days.",
      "url": "https://finnhub.io/api/news?id=a4d1603df39e6d5c3d6208cb4aa5419cb3cf80daa0a6805899a1ecb7c4dee65f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-25",
      "description": "xslF345X05/form4-07252025_040701.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/xslF345X05/form4-07252025_040701.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753219662.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753217727.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/xslF345X05/wk-form4_1753217727.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753216439.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753215735.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/xslF345X05/wk-form4_1753215735.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}